Fabricant Ends Eventful Service In FDA Supplement Regulation To Head NPA
This article was originally published in The Tan Sheet
Daniel Fabricant will be the CEO of NPA, and leave his post as director of FDA’s Division of Dietary Supplement Programs, the association announced April 8.
You may also be interested in...
Trade groups say FDA committed to revisiting issues in the NDI draft guidance including how firms prove ingredients’ grandfathered status, notifications required for ingredients or finished products and data necessary to demonstrate NDI safety. The agency’s decision followed a meeting between industry allies Sens. Hatch and Harkin and FDA Commissioner Hamburg.
The Natural Products Association names John Spitaleri Shaw executive director and CEO, nearly six months after the departure of his predecessor, John Gay. Shaw is a former senior VP at the Portland Cement Association and a newcomer to the consumer packaged goods industry.
Dietary supplement industry trade groups disavow statements by Jarrow Formulas’ president that cast as industry consensus his criticism of Daniel Fabricant’s work as FDA’s top supplement program official.